Adar1 Capital Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.70B
Q ending 2026-03-31
Prior quarter
$1.36B
Q ending 2025-12-31
Change
+24.8% QoQ · +215.3% YoY
Positions
310
reported holdings
Largest positions
Top 100 of 310 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Abivax Sa | ABVX | Shares | $155.2M | 1.4M |
| Protagonist Therapeutics Inc | PTGX | Shares | $104.8M | 994K |
| Roivant Sciences Ltd | Shares | $91.0M | 3.3M | |
| Immunovant Inc | IMVT | Shares | $66.5M | 2.7M |
| State Str Spdr S&P 500 Etf T | SPY | Shares | $49.4M | 76K |
| Terns Pharmaceuticals Inc | 430 | Shares | $48.2M | 915K |
| Cytokinetics Inc | CYTK | Shares | $41.7M | 633K |
| Crinetics Pharmaceuticals In | CRNX | Shares | $41.4M | 1.1M |
| Ea Series Trust | BOXX | Shares | $39.2M | 337K |
| Denali Therapeutics Inc | DNLI | Shares | $35.9M | 1.9M |
| Beam Therapeutics Inc | BEAM | Shares | $34.5M | 1.4M |
| Zai Lab Ltd | ZLAB | Shares | $26.8M | 1.4M |
| Septerna Inc | SEPN | Shares | $26.2M | 1.1M |
| Vir Biotechnology Inc | VIR | Shares | $24.6M | 2.7M |
| Dbv Technologies S A | DBVT | Shares | $21.2M | 1.0M |
| Anteris Technologies Global | AVR | Shares | $21.0M | 3.8M |
| Inspire Med Sys Inc | INSP | Shares | $20.9M | 405K |
| Scholar Rock Hldg Corp | SRRK | Shares | $20.0M | 407K |
| Rhythm Pharmaceuticals Inc | RYTM | Shares | $18.4M | 211K |
| Spyre Therapeutics Inc | SYRE | Shares | $17.1M | 338K |
| Cytomx Therapeutics Inc. | CTMX | Shares | $16.0M | 3.4M |
| Prothena Corp Plc | Shares | $15.4M | 1.6M | |
| Sanofi Sa | SNY | Shares | $15.3M | 317K |
| Vaxcyte Inc | PCVX | Shares | $15.1M | 259K |
| Monopar Therapeutics Inc | MNPR | Shares | $14.5M | 264K |
| Arbutus Biopharma Corp | ABUS | Shares | $14.1M | 3.1M |
| Amylyx Pharmaceuticals Inc | AMLX | Shares | $13.9M | 1.0M |
| Celldex Therapeutics Inc New | CLDX | Shares | $13.6M | 428K |
| Taysha Gene Therapies Inc | TSHA | Shares | $13.3M | 3.0M |
| Xenon Pharmaceuticals Inc | XENE | Shares | $13.3M | 229K |
| Sutro Biopharma Inc | STRO | Shares | $13.1M | 524K |
| Revolution Medicines Inc | RVMD | Shares | $13.0M | 134K |
| Enliven Therapeutics Inc | ELVN | Shares | $12.9M | 330K |
| Cg Oncology Inc | CGON | Shares | $12.6M | 186K |
| Spdr Series Trust | BIL | Shares | $12.4M | 136K |
| Establishment Labs Hldgs Inc | Shares | $12.1M | 213K | |
| Replimune Group Inc | REPL | Shares | $12.1M | 1.6M |
| Inventiva Sa | IVA | Shares | $12.1M | 2.2M |
| Ionis Pharmaceuticals Inc | IONS | Shares | $12.0M | 160K |
| Nektar Therapeutics | NKTR | Shares | $11.6M | 161K |
| Inhibikase Therapeutics Inc | IKT | Shares | $11.1M | 6.6M |
| Ars Pharmaceuticals Inc | SPRY | Shares | $10.9M | 1.4M |
| Terns Pharmaceuticals Inc | 430 | Call | $10.5M | 200K |
| Helix Acquisition Corp Iii | Shares | $10.3M | 1.0M | |
| Ovid Therapeutics Inc | OVID | Shares | $10.1M | 4.5M |
| Onkure Therapeutics Inc | OKUR | Shares | $10.1M | 2.4M |
| Regeneron Pharmaceuticals | REGN | Shares | $9.4M | 12K |
| Moonlake Immunotherapeutics | MLTX | Shares | $8.5M | 457K |
| Lexeo Therapeutics Inc | LXEO | Shares | $8.4M | 1.5M |
| Opus Genetics Inc | IRD | Shares | $8.4M | 1.8M |
| Teva Pharmaceutical Inds Ltd | TEVA | Shares | $8.1M | 268K |
| Savara Inc | SVRA | Shares | $8.0M | 1.5M |
| Maplight Therapeutics Inc | MPLT | Shares | $7.6M | 375K |
| Leonabio Inc | LONA | Shares | $7.5M | 727K |
| Equillium Inc | EQ | Shares | $7.5M | 3.7M |
| Viking Therapeutics Inc | VKTX | Shares | $7.4M | 228K |
| Damora Therapeutics Inc | DMRA | Shares | $7.2M | 279K |
| Urogen Pharma Ltd | Shares | $7.1M | 395K | |
| Bridgebio Pharma Inc | BBIO | Shares | $7.0M | 94K |
| Prime Medicine Inc | PRME | Shares | $6.9M | 2.0M |
| Ishares Tr | IWM | Put | $6.8M | 28K |
| Vertex Pharmaceuticals Inc | VRTX | Shares | $6.7M | 15K |
| Korro Bio Inc | KRRO | Shares | $6.1M | 540K |
| Viridian Therapeutics Inc | VRDN | Shares | $6.0M | 304K |
| Danaher Corp Del | DHR | Shares | $5.9M | 31K |
| Insmed Inc | INSM | Shares | $5.8M | 35K |
| Ascendis Pharma A/S | Shares | $5.7M | 25K | |
| Brighthouse Finl Inc | BHF | Shares | $5.7M | 96K |
| Sarepta Therapeutics Inc | SRPT | Shares | $5.7M | 262K |
| Oaktree Acquisition Corp Iii | Shares | $5.5M | 516K | |
| Perceptive Cap Solutions Cor | Shares | $5.5M | 500K | |
| Krystal Biotech Inc | KRYS | Shares | $5.2M | 20K |
| Acumen Pharmaceuticals Inc | ABOS | Shares | $5.1M | 2.2M |
| Invivyd Inc | IVVD | Shares | $5.0M | 3.8M |
| Bridgebio Pharma Inc | BBIO 2.25 02/01/29 | Principal | $4.9M | 45K |
| Bhav Acquisition Corp | Shares | $4.9M | 495K | |
| Protara Therapeutics Inc | TARA | Shares | $4.9M | 941K |
| Abivax Sa | ABVX | Call | $4.9M | 44K |
| Bridgebio Pharma Inc | BBIO 1.75 03/01/31 | Principal | $4.9M | 30K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $4.8M | 141K |
| Eli Lilly & Co | LLY | Shares | $4.7M | 5K |
| Dianthus Therapeutics Inc | DNTH | Shares | $4.6M | 55K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $4.4M | 70K |
| Belite Bio Inc | BLTE | Shares | $4.3M | 27K |
| Evommune Inc | EVMN | Shares | $4.2M | 184K |
| Mineralys Therapeutics Inc | MLYS | Shares | $4.2M | 155K |
| Janux Therapeutics Inc | JANX | Shares | $4.1M | 299K |
| Climb Bio Inc | CLYM | Shares | $4.1M | 598K |
| Palisade Bio Inc | PALI | Shares | $4.0M | 2.3M |
| American Exceptionalism Acqu | Shares | $3.9M | 358K | |
| Spruce Biosciences Inc | SPRB | Shares | $3.8M | 59K |
| Newamsterdam Pharma Company | Shares | $3.8M | 119K | |
| Liquidia Corporation | LQDA | Put | $3.8M | 100K |
| Zura Bio Ltd | Shares | $3.8M | 630K | |
| Arcellx Inc | ACLX | Shares | $3.7M | 32K |
| Contineum Therapeutics Inc | CTNM | Shares | $3.6M | 277K |
| Bridgebio Pharma Inc | BBIO 2.5 03/15/27 | Principal | $3.6M | 20K |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $3.5M | 216K |
| Beone Medicines Ltd | ONC | Shares | $3.5M | 12K |
| Tenax Therapeutics Inc | TENX | Shares | $3.4M | 213K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.